Recombinant human erythropoietin protects long-term cultured ageing primary nerve cells by upregulating the PI3K/Akt pathway. [PDF]
Wang H +5 more
europepmc +1 more source
Recombinant human erythropoietin therapy in patients with cancer: efficacy, risks and the controversy of EpoR expression. [PDF]
Sturiale A +20 more
europepmc +1 more source
Efficacy of acupoint injection of recombinant human erythropoietin in the treatment of postoperative hemorrhagic anemia in elderly patients with femoral intertrochanteric fracture. [PDF]
Fan L, Jiang Y, Tao X.
europepmc +1 more source
Red blood cell lifespan in long-term hemodialysis patients treated with roxadustat or recombinant human erythropoietin. [PDF]
Yang X +8 more
europepmc +1 more source
Identification of Candidate Blood Biomarkers of Recombinant Human Erythropoietin Administration Using Targeted Polar Metabolomics by HILIC-MS/MS. [PDF]
Salamin O +5 more
europepmc +1 more source
Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis. [PDF]
Chuengsaman P +2 more
europepmc +1 more source
Recombinant Human Erythropoietin Effects on Well-Trained Athletes' Endurance Performance: A Systematic Review. [PDF]
Alberdi-Garciandia A +1 more
europepmc +1 more source
Recombinant human erythropoietin induces neuroprotection, activates MAPK/CREB pathway, and rescues fear memory after traumatic brain injury with delayed hypoxemia in mice. [PDF]
Celorrio M +8 more
europepmc +1 more source
Effect of recombinant human erythropoietin on postoperative anemia in children and adolescents undergoing osteosarcoma and potential influencing factors: a single-center retrospective study. [PDF]
Liu L +6 more
europepmc +1 more source
Recombinant human erythropoietin attenuates hepatic dysfunction by suppressing hepatocellular apoptosis in lipopolysaccharide-induced disseminated intravascular coagulation in rats. [PDF]
Suga Y +4 more
europepmc +1 more source

